Figure 1
Figure 1. Donor T cells cause accelerated GVHD in IDO−/− versus wt recipients. (A) B6 or IDO−/− mice were lethally irradiated (9.0 Gy) and infused with 107 MHC-mismatched Balb/c non–T cell–depleted BM with or without 3 × 106 Balb/c CD4+ T cells. Survival plots of B6 versus IDO−/− recipients are shown. ● indicates BM→B6; ■, CD4+ T cells→B6; ○, BM→IDO−/−; □, CD4+ T cells→IDO−/− (P < .03). Data are from one experiment; n = 8 mice/group. (B) B6 or IDO−/− mice were lethally irradiated and given Balb/c TCD BM with or without 3 × 106 donor CD4+ and CD8+ T cells. Survival plots of B6 vs IDO−/− recipients are shown. ● indicates BM→B6; ■, CD4+ and CD8+ T cells→B6; ○, BM→IDO−/−; □, CD4+ and CD8+ T cells→IDO−/− (P < .04). Data are from one experiment; n = 8 mice/group. (C) Balb/c or IDO−/− mice were lethally irradiated (7.0 Gy) and infused with 107 B6 TCD BM with or without 2 × 106 CD4+ and CD8+ T cells. Survival plots of Balb/c versus IDO−/− recipients are shown. ● indicates BM→Balb/c; ■, CD4+ and CD8+ T cells→Balb/c; ○, BM→IDO−/−; □, CD4+ and CD8+ T cells→IDO−/−. Data are pooled from 2 experiments; n = 16 mice/group (P < .001).

Donor T cells cause accelerated GVHD in IDO−/− versus wt recipients. (A) B6 or IDO−/− mice were lethally irradiated (9.0 Gy) and infused with 107 MHC-mismatched Balb/c non–T cell–depleted BM with or without 3 × 106 Balb/c CD4+ T cells. Survival plots of B6 versus IDO−/− recipients are shown. ● indicates BM→B6; ■, CD4+ T cells→B6; ○, BM→IDO−/−; □, CD4+ T cells→IDO−/− (P < .03). Data are from one experiment; n = 8 mice/group. (B) B6 or IDO−/− mice were lethally irradiated and given Balb/c TCD BM with or without 3 × 106 donor CD4+ and CD8+ T cells. Survival plots of B6 vs IDO−/− recipients are shown. ● indicates BM→B6; ■, CD4+ and CD8+ T cells→B6; ○, BM→IDO−/−; □, CD4+ and CD8+ T cells→IDO−/− (P < .04). Data are from one experiment; n = 8 mice/group. (C) Balb/c or IDO−/− mice were lethally irradiated (7.0 Gy) and infused with 107 B6 TCD BM with or without 2 × 106 CD4+ and CD8+ T cells. Survival plots of Balb/c versus IDO−/− recipients are shown. ● indicates BM→Balb/c; ■, CD4+ and CD8+ T cells→Balb/c; ○, BM→IDO−/−; □, CD4+ and CD8+ T cells→IDO−/−. Data are pooled from 2 experiments; n = 16 mice/group (P < .001).

Close Modal

or Create an Account

Close Modal
Close Modal